BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37355897)

  • 1. Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
    Fu XX; Wei B; Cao HM; Duan R; Deng Y; Lian HW; Zhang YD; Jiang T
    J Alzheimers Dis; 2023; 94(3):919-933. PubMed ID: 37355897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APP
    Yang C; Liu G; Zeng X; Xiang Y; Chen X; Le W
    Redox Biol; 2024 Apr; 70():103006. PubMed ID: 38241837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease.
    Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L
    J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
    Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
    J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parthenolide alleviates microglia-mediated neuroinflammation via MAPK/TRIM31/NLRP3 signaling to ameliorate cognitive disorder.
    Fan M; Wang C; Zhao X; Jiang Y; Wang C
    Int Immunopharmacol; 2023 Jul; 120():110287. PubMed ID: 37182449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice.
    Bai D; Jin G; Zhang D; Zhao L; Wang M; Zhu Q; Zhu L; Sun Y; Liu X; Chen X; Zhang L; Li W; Cui Y
    J Physiol Sci; 2019 Jul; 69(4):643-652. PubMed ID: 31087219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treadmill Exercise Promotes Microglial β-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice.
    Liang F; Sun F; He B; Wang J
    Neuroscience; 2022 May; 491():122-133. PubMed ID: 35398179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.
    Bao J; Liu W; Zhou HY; Gui YR; Yang YH; Wu MJ; Xiao YF; Shang JT; Long GF; Shu XJ
    Curr Med Sci; 2020 Feb; 40(1):18-27. PubMed ID: 32166661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway.
    Shan X; Tao W; Li J; Tao W; Li D; Zhou L; Yang X; Dong C; Huang S; Chu X; Zhang C
    J Ethnopharmacol; 2024 Jul; 329():118145. PubMed ID: 38582153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinacoside Improves Cognitive Impairment by Inhibiting Aβ Deposition Through the PI3K/AKT/Nrf2/PPARγ Signaling Pathways in APP/PS1 Mice.
    Qiu H; Liu X
    Mol Neurobiol; 2022 Aug; 59(8):4987-4999. PubMed ID: 35665898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mulberry Fruit Extract Alleviates Cognitive Impairment by Promoting the Clearance of Amyloid-β and Inhibiting Neuroinflammation in Alzheimer's Disease Mice.
    Liu D; Du D
    Neurochem Res; 2020 Sep; 45(9):2009-2019. PubMed ID: 32488469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
    Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
    J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omaveloxolone ameliorates cognitive dysfunction in APP/PS1 mice by stabilizing the STAT3 pathway.
    Cui X; Zong S; Song W; Wang C; Liu Y; Zhang L; Xia P; Wang X; Zhao H; Wang L; Lu Z
    Life Sci; 2023 Dec; 335():122261. PubMed ID: 37951537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl Itaconate Reduces Cognitive Impairment and Neuroinflammation in APPswe/PS1ΔE9 Transgenic Mouse Model of Alzheimer's Disease.
    Xiong J; Lu DL; Chen BQ; Liu TY; Wang ZX
    Neuromolecular Med; 2023 Jun; 25(2):179-192. PubMed ID: 35939256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice.
    Li X; Huang L; Kong L; Su Y; Zhou H; Ji P; Sun R; Wang C; Li W; Li W
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36367174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.